Cardiac natriuretic peptides: from basic discovery to clinical practice.
about
RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.Ageing is a risk factor in imatinib mesylate cardiotoxicityUsefulness of running wheel for detection of congestive heart failure in dilated cardiomyopathy mouse model.Collecting duct principal cell transport processes and their regulation.Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis.Prognostic Value of Adrenomedullin and Natriuretic Peptides in Uroseptic Patients Induced by Ureteroscopy.Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy.Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization.Old tool - new application: NT-proBNP in fetal medicine.Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.Patient-Specific Relationship Between Hydraulic Permeability of Microvasculature and the Extent of Burden of Excess Fluid in Hemodialysis Patients.Acute Biochemical, Cardiovascular, and Autonomic Response to Hyperbaric (4 atm) Exposure in Healthy Subjects.
P2860
Q34257330-3F9D3535-726C-4F60-A94A-27E629AC9CE7Q34548719-C36C5903-58BC-402F-AFCB-516B169F0033Q34576662-511C1BD9-07A9-4741-839A-3E70AFE229FEQ34828709-4D4DB978-C5FA-4823-994C-D237995B5995Q36069585-2F402AC4-5A9B-40F1-908D-A37FBEDA20B0Q36530338-DCFD8CA7-728F-4C5E-97E7-0B6A8B48F41BQ36698572-7B98D30E-CB83-424B-B8F3-D3C22E362E49Q38137849-03E53962-4019-4487-8FA7-63E845E9E668Q38623581-468A0DC3-19BC-4467-907B-B73BE9A8B64AQ38977632-A503B64E-ACDD-48A8-B3B3-DB5D94D88168Q42583421-2931B4BC-E2FC-439D-94DA-A3CC110575B8Q43968441-1623FC52-8239-4FAB-973B-0D0AAA682B14Q49043967-F5079538-6BD5-42BD-B141-1E4BC3482910Q51136236-44CADE61-9526-42F5-8854-1A8FD29A80C5Q55439750-D5E84EFC-BB1C-4DAE-A764-9A599EB96FF3
P2860
Cardiac natriuretic peptides: from basic discovery to clinical practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@en
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@nl
type
label
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@en
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@nl
prefLabel
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@en
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@nl
P2860
P1476
Cardiac natriuretic peptides: from basic discovery to clinical practice.
@en
P2093
Salim Hayek
P2860
P304
P356
10.1111/J.1755-5922.2010.00152.X
P50
P577
2010-04-23T00:00:00Z